
Psychedelic therapies surge in trials, but safety varies by substance—learn key benefits, risks, and why psychiatric history raises complications.

Dr Yaden is the Griffiths Professor in Psychedelic Research at Johns Hopkins University School of Medicine in the Department of Psychiatry and Behavioral Sciences in the Center for Psychedelic and Consciousness Research. He is a research associate at the University of Oxford and the cofounder of the Hub at Oxford for Psychedelic Ethics (HOPE). He studies brief experiences with the potential for long-term positive impact. His current research at the Yaden Lab focuses on psychedelic experiences, including their risks, benefits, and mechanisms.

Psychedelic therapies surge in trials, but safety varies by substance—learn key benefits, risks, and why psychiatric history raises complications.